PBM reforms and regulatory changes have reshaped the industry landscape.
Thomas L. Pile, PharmD, CDCES
Advertisement
Articles by Thomas L. Pile, PharmD, CDCES
Innovations are expanding opportunities for care.
Clinical trials are using AI to handle large and complex volumes of data to develop oncology, cardiovascular, and neurologic compounds and to integrate molecular and imaging data.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
GLP-1 Receptor Agonists Show Promise Across Alcohol, Opioid, and Tobacco Use Disorders
2
UConn’s Medical Writing Certificate Program: It’s Just "Write"
3
TACTI-004 Trial Studying Eftilagimod Alfa With Pembrolizumab in Advanced NSCLC to Begin Evaluation
4
Pharmacy Policy Updates for October 2025
5
